BRCA-mutated breast cancer

Breakthrough DNA Repair Inhibitor Advances Rapidly Toward Clinic: Artios’ ART6043 Earns FDA Fast Track Status for Resistant Breast Cancer

Post author:Bree Clare
Post published:March 16, 2026
Post category:BRCA-mutated Breast Cancer

Artios Pharma has achieved a significant milestone in cancer treatment development with the U.S. Food and Drug Administration's granting of Fast Track designation to ART6043, a potentially first-in-class DNA polymerase…

source: pixabay.com

IDEAYA’s IDE161 Receives Fast Track Designation for HR+ Her2- Breast Cancer

Post author:Rose Duesterwald
Post published:December 4, 2023
Post category:BRCA-mutated Breast Cancer BRCA-Mutations Breast Cancer

The FDA has granted IDEAYA Biosciences fast track status for IDE161 as a treatment for HR+, Her2- breast cancer. The therapy is a selective inhibitor of ADP ribose glycohydrolase…

Source: Pixabay

LYNPARZA Trial for BRCA-Mutated HER2-Negative Breast Cancer Achieved iDFS Superiority Boundary

Post author:Jessica Lynn
Post published:March 4, 2021
Post category:BRCA-mutated Breast Cancer BRCA-Mutations Breast Cancer

In a joint statement, biopharmaceutical companies AstraZeneca and Merck & Co., Inc. ("Merck") shared that LYNPARZA (olaparib) achieved a superiority boundary in the Phase 3 OlympiA clinical trial. During…

source: pixabay.com

A Courageous Decision: The Valdez Twins Decided to Stop Cancer Before It Started

Post author:Rose Duesterwald
Post published:October 28, 2020
Post category:BRCA-mutated Breast Cancer Breast Cancer Rare Disease

Twins Iris and Clarisa Valdez recently shared their story of courage and hope and thanked the City of Hope care team for its guidance and support. But most importantly…

pandoraferrari / Pixabay

BRCA-Mutated Breast Cancer May Negatively Impact Fertility

Post author:Jessica Lynn
Post published:April 20, 2020
Post category:BRCA-mutated Breast Cancer BRCA-Mutations Breast Cancer

A recent release from Yale University highlights research from Dr. Kutluk Oktay, a fertility expert, on how BRCA-mutated breast cancer may affect fertility following chemotherapy treatments. His findings suggest that women…

Women with Breast Cancer Risk Must Weigh the Unknowns of Certain Types of MRIs

Post author:Trudy Horsting
Post published:June 14, 2019
Post category:BRCA-mutated Breast Cancer Breast Cancer Rare Disease

Meredith Resnick's breast cancer risk is 42%. This risk is made up of her higher breast density (denser breasts are associated with increased risk), Ashkenazi Jewish heritage, a family history…

The Latest Advances in Triple Negative Breast Cancer

Post author:Rose Duesterwald
Post published:April 4, 2019
Post category:BRCA-mutated Breast Cancer Breast Cancer

OncLive recently published the views of several speakers at its State of the Science Summit on breast cancer. Stephanie LaBomascus, MD gave a presentation that highlighted triple negative breast…

source: pixabay.com

Women Negative for BRCA Mutations Still Need Breast Cancer Screenings

Post author:Scott Carlson
Post published:January 29, 2019
Post category:BRCA-Mutations Breast Cancer

An article originally published by CBS New York recently emphasized the importance of regular mammograms for detecting breast cancer, even in families with no history of mutated BRCA genes. What…

Looking Back With Humor: She Survived and Wrote a Book About How She Fought For Her Children, Her Life, and Her Sanity

Post author:Rose Duesterwald
Post published:January 1, 2019
Post category:BRCA-mutated Breast Cancer Breast Cancer

Stephanie Hosford was recently interviewed by CURE (Cancer Updates Research and Education) about what she now calls her “three crazy days”. The title of her book is “Bald, Fat and…

80% of People at Risk for Cancer Don’t Know it- Do You?

Post author:Trudy Horsting
Post published:October 1, 2018
Post category:BRCA-mutated Breast Cancer BRCA-Mutations Pancreatic Cancer

A new study has found that 80 percent of people who have an identifiable genetic risk for cancer due to a mutated BRCA1/2 gene don’t know they're at risk. The…

Parentingupstream / Pixabay

ICYMI: Study Suggests That PARP Inhibitors Could be a Effective for BRCA Mutated Breast Cancer

Post author:James Moore
Post published:September 8, 2018
Post category:BRCA-mutated Breast Cancer

According to a story from Oncology Times, a recent study indicates that the PARP inhibitor drug talazoparib could be an effective treatment option for patients with advanced, HER-2 negative, BRCA…

PublicDomainPictures / Pixabay

Women on Medicare Aren’t Getting Genetic Tests for Breast and Ovarian Cancer

Post author:James Moore
Post published:September 5, 2018
Post category:BRCA-mutated Breast Cancer BRCA-Mutations Ovarian Cancer

According to a story from medicinenet.com, a recent study found that women on Medicare are not getting genetic tests for BRCA mutations that could lead to ovarian cancer and breast…

Important Questions to Ask After a Breast Cancer Diagnosis

Post author:Athena Lee
Post published:August 20, 2018
Post category:Metastatic Breast Cancer

According to the Dover Post, there are a few crucial questions to ask your doctor upon being diagnosed with breast cancer. By asking these crucial questions, patients will be…

geralt / Pixabay

Important Protein Complex That Allows Certain Cancer Drugs to be Effective is Discovered

Post author:James Moore
Post published:August 1, 2018
Post category:Ovarian Cancer

According to a story from rdmag.com, researchers from the University of Toronto have discovered a critical mechanism that helps facilitate the normal DNA repair process. This mechanism could have implications…

JoshMB / Pixabay

Study Offers Free Screening for Cancer and BRCA Mutations for Ashkenazi Jewish Community

Post author:James Moore
Post published:July 10, 2018
Post category:BRCA-mutated Breast Cancer BRCA-Mutations Ovarian Cancer

According to a story from Jewish Community Voice, the BRCA Founder Outreach Study, which is a national, cancer-focused research study, is offering free screenings for people of Ashkenazi Jewish descent.…

silviarita / Pixabay

A Woman’s Severe Breast Cancer Was Eliminated Using New Immunotherapy Approach

Post author:James Moore
Post published:June 6, 2018
Post category:BRCA-mutated Breast Cancer Breast Cancer Ovarian Cancer

According to a story from The Guardian, doctors are celebrating the effectiveness of an all new, experimental immunotherapy that was able to totally eliminate a case of metastatic breast cancer…

source: pixabay.com

Do Animals Hold The Key to Understanding Cancer?

Post author:James Moore
Post published:June 5, 2018
Post category:BRCA-mutated Breast Cancer Osteosarcoma Rare Disease

According to a story from cancer.nautil.us, some cancer researchers are beginning to look at the animal kingdom in order to find new answers for finding what it takes to beat…

source: pixabay.com

Some People Are Resistant to PARP Inhibitors, and Researchers Have Just Discovered Why

Post author:James Moore
Post published:May 28, 2018
Post category:BRCA-mutated Breast Cancer Ovarian Cancer Rare Disease

According to a story from Ovarian Cancer News, a recent study has allowed scientists to determine why some people appear to be resistant to poly ADP ribose polymerase (PARP) inhibitors.…

Source: Pixabay

Genetic Screening Can Prevent Parents from Passing on Genes Linked to Some Diseases

Post author:Anna Hewitt
Post published:May 28, 2018
Post category:Cystic Fibrosis Rare Disease Sickle cell anemia

The Young family from Oregon, U.S. have used genetic screening to test their embryos for a variation of the BRCA gene that significantly increases the risk of breast cancer, reports…

Source: Pixabay

Do You Know the Facts About Getting Tested for Genetic Cancer?

Post author:Octavia Walker
Post published:April 25, 2018
Post category:BRCA-mutated Breast Cancer BRCA-Mutations Ovarian Cancer Pancreatic Cancer

Do you have to be tested for an inherited gene mutation if you have already had cancer? Can a woman get a genetic mutation from her father? If you have…

source: pixabay.com

Treatment for BRCA-Mutated Breast Cancer Makes Another Regulatory Hurdle in the EU

Post author:James Moore
Post published:April 9, 2018
Post category:BRCA-mutated Breast Cancer

According to a story from mrknewsroom.com, the pharmaceutical companies Merck and AstraZeneca recently announced that the marketing application for the investigational drug olaparib (brand name Lynparza) was recently certified for…

typographyimages / Pixabay

Here’s What You Should Know Before Taking 23andMe’s BRCA-Mutated Breast Cancer Test

Post author:James Moore
Post published:April 6, 2018
Post category:BRCA-mutated Breast Cancer BRCA-Mutations

According to a story from sunmag.net, 23andMe, the genetics testing company widely known for its ancestral analysis measures, is now offering a genetics test to measure your risk of BRCA1…

source: pixabay.com

Glowing Dye is Helping Doctors Locate Rare, Hidden Cancer

Post author:James Moore
Post published:March 27, 2018
Post category:BRCA-mutated Breast Cancer Esophageal Cancer Ovarian Cancer

According to a story from CBS DFW, doctors have begun to test the use of fluorescent dyes in order to detect hidden cancer tumors. So far, the dyes appear to…

Source: Pixabay

Author Emma Hannigan Leaves a Legacy of Inspiration

Post author:Samuel Sachs
Post published:March 13, 2018
Post category:BRCA-mutated Breast Cancer BRCA-Mutations Ovarian Cancer

Author Emma Hannigan passed away March 3rd 2018. Hannigan led a life of strength and dignity, persevering through her cancer diagnosis. Her husband, Cian, left a touching tribute to his…

pixel2013 / Pixabay

Author Emma Hannigan Reveals The Beginning of the End of Her Fight With Breast Cancer

Post author:James Moore
Post published:February 22, 2018
Post category:BRCA-mutated Breast Cancer

According to a story from independent.ie, acclaimed author Emma Hannigan announced that her final options for treatment had been exhausted in her fight with BRCA-mutated breast cancer. Her doctors have…

Breakthrough DNA Repair Inhibitor Advances Rapidly Toward Clinic: Artios’ ART6043 Earns FDA Fast Track Status for Resistant Breast Cancer

IDEAYA’s IDE161 Receives Fast Track Designation for HR+ Her2- Breast Cancer

LYNPARZA Trial for BRCA-Mutated HER2-Negative Breast Cancer Achieved iDFS Superiority Boundary

A Courageous Decision: The Valdez Twins Decided to Stop Cancer Before It Started

BRCA-Mutated Breast Cancer May Negatively Impact Fertility

Women with Breast Cancer Risk Must Weigh the Unknowns of Certain Types of MRIs

The Latest Advances in Triple Negative Breast Cancer

Women Negative for BRCA Mutations Still Need Breast Cancer Screenings

Looking Back With Humor: She Survived and Wrote a Book About How She Fought For Her Children, Her Life, and Her Sanity

80% of People at Risk for Cancer Don’t Know it- Do You?

ICYMI: Study Suggests That PARP Inhibitors Could be a Effective for BRCA Mutated Breast Cancer

Women on Medicare Aren’t Getting Genetic Tests for Breast and Ovarian Cancer

Important Questions to Ask After a Breast Cancer Diagnosis

Important Protein Complex That Allows Certain Cancer Drugs to be Effective is Discovered

Study Offers Free Screening for Cancer and BRCA Mutations for Ashkenazi Jewish Community

A Woman’s Severe Breast Cancer Was Eliminated Using New Immunotherapy Approach

Do Animals Hold The Key to Understanding Cancer?

Some People Are Resistant to PARP Inhibitors, and Researchers Have Just Discovered Why

Genetic Screening Can Prevent Parents from Passing on Genes Linked to Some Diseases

Do You Know the Facts About Getting Tested for Genetic Cancer?

Treatment for BRCA-Mutated Breast Cancer Makes Another Regulatory Hurdle in the EU

Here’s What You Should Know Before Taking 23andMe’s BRCA-Mutated Breast Cancer Test

Glowing Dye is Helping Doctors Locate Rare, Hidden Cancer

Author Emma Hannigan Leaves a Legacy of Inspiration

Author Emma Hannigan Reveals The Beginning of the End of Her Fight With Breast Cancer

Let’s Work Together!

Keep Up to Date

Learn More